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Brief Communication
Increased brain microvascular MMP-9 and
incidence of haemorrhagic transformation in obese
mice after experimental stroke
Barry WMcColl, Nicola Rose, Fiona H Robson, Nancy J Rothwell and Catherine B Lawrence
Faculty of Life Sciences, University of Manchester, Manchester, UK
Obesity is an independent risk factor for stroke and is associated with poorer outcome after stroke.
We investigated whether this poorer outcome is related to brain microvascular disruption. Focal
cerebral ischaemia was induced in lean or obese (ob/ob) mice by transient middle cerebral artery
occlusion. The incidence of haemorrhagic transformation and the volume of ischaemic brain
damage were significantly greater in obese mice. Blood–brain barrier permeability and brain
microvascular MMP-9 expression were also markedly increased in obese mice. These effects were
independent of leptin or glycaemic status, suggesting that obesity potentiates brain microvascular
disruption after experimental stroke.
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Introduction
Obesity is an independent risk factor for stroke, and
is associated with atherosclerosis, diabetes, and
hypertension, conditions that predispose to stroke
(Winter et al, 2008). The increased risk of stroke in
obese individuals may also be accompanied by
poorer prognosis after the ischaemic insult (Razinia
et al, 2007). In support of this, recent studies have
demonstrated greater brain damage in obese rodents
after experimental stroke (Mayanagi et al, 2008;
Terao et al, 2008). However, the mechanisms respon-
sible for these detrimental effects of obesity on
cerebrovascular injury are poorly delineated.
A crucial site of convergence for pathophysiologi-
cal mechanisms involved in obesity and stroke is the
brain microvascular endothelium. Obesity is a state
of chronic systemic inflammation and is associated
with vascular oxidative stress (Dandona et al, 2004).
Inflammation and oxidative stress are important
factors that contribute to disruption of the blood–
brain barrier (BBB). Mechanisms include disruption
of inter-endothelial tight-junction complexes
(Schreibelt et al, 2007) and induction of proteases,
in particular matrix metalloproteinases (MMPs), that
degrade constituents of the vascular basement mem-
brane (Zhao et al, 2007). We have shown previously
that systemic inflammation exacerbates ischaemic
brain damage through MMP-9-dependent alterations
in BBB integrity (McColl et al, 2008). Clinically, loss
of BBB integrity after stroke is associated with
serious complications such as brain oedema and
haemorrhagic transformation (HT) that correlate with
poor prognosis (Simard et al, 2007). Accordingly, it is
feasible that obesity may predispose to poorer
outcome after stroke through aggravation of brain
microvascular disruption.
In the present study, we sought to determine if




Experiments were performed on 8- to 12-week-old male
obese ob/ob (C57BL/6OlaHsd-Lepob) or lean littermate mice
(Harlan-Olac, Bicester, UK) according to the Animals
(Scientific Procedures) Act (1986). Body weight and blood
glucose concentration at the time of surgery were as
follows: body weight, lean 29.0±0.5 g versus ob/ob
47.3±0.9 g (P<0.001) and glucose, lean 9.3±0.7mmol/L
versus ob/ob 10.1±1.4mmol/L (P>0.05). Focal ischaemia
was induced by transient (40mins) middle cerebral artery
occlusion (MCAo) as previously described (McColl et al,
2008). Briefly, under isoflurane anaesthesia, the carotid
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arteries were exposed and a 6-0 nylon monofilament
(Dermalon) with a 2mm tip (180 mm diameter) coated in
thermo-melting glue (Jet Melt) was introduced into the
external carotid artery and advanced 9mm along the
internal carotid artery until occluding the origin of the
MCA. After 40mins, the filament was withdrawn to
establish reperfusion and the wound sutured.
In a separate experiment, lean and obese ob/ob mice were
administered an intraperitoneal injection of vehicle (0.9%
sterile saline) or leptin (4mg/kg in saline; Peprotech, London,
UK) at the onset of MCAo. This dose of leptin has been shown
previously to reduce ischaemic injury (Zhang et al, 2007).
Tissue Processing
Twenty-four hours after MCAo mice were perfused trans-
cardially with 0.9% saline followed by 4% paraformalde-
hyde and brains post-fixed, cryoprotected, and frozen.
Coronal brain sections (20mm) were prepared on a cryostat.
Measurement of HT and Ischaemic Damage
To assess HT brain sections were stained with haematox-
ylin and eosin. Areas of HT were delineated at coronal
levels (400 mm apart) and the total area of HT was
calculated. For ischaemic damage, adjacent brain sections
were stained with cresyl violet. Briefly, areas of damage
were delineated at eight anatomically defined coronal
levels and the total volume was calculated.
Immunohistochemistry
Primary antibodies were used as follows: goat anti-MMP-9
(1:400; R&D Systems, Abington, UK), and rabbit anti-
laminin (1:25; Sigma, Poole, UK). Endogenous peroxidise
activity (except for double immunofluorescence) and
nonspecific binding sites were blocked before incubating
(41C) sections in primary antibody solution. For perox-
idise-based staining, sections were then incubated in
biotinylated secondary antibody (1:200; Vector Labora-
tories, Peterborough, UK), immersed in avidin–biotin–
peroxidase complex (ABC; Vector Laboratories) and col-
our-developed using a 0.05% diaminobenzidine solution
(in 0.01% H2O2). For assessment of BBB disruption,
primary antibody was omitted and a biotinylated anti-
mouse IgG secondary antibody was used. For double
labelling immunofluorescence, after primary antibody
application sections were incubated in donkey anti-goat
Alexa 488 and donkey anti-rabbit 594 (Molecular Probes,
Paisley, UK), mounted, and coverslipped with ProLong
Gold mounted medium (Invitrogen, Paisley, UK).
Statistical Analysis
For all analyses, data are represented as mean±s.d.
Parametric data were analysed using Student’s t-test for
single comparisons, or one-way analysis of variance
followed by a Tukey’s test for multiple comparisons. The
incidence of HT was compared using w2-test.
Results
Increased Incidence of HT and Ischaemic Brain
Damage in Obese Mice
Haemorrhagic transformation was observed in the
ipsilateral ischaemic hemisphere of ob/ob mice.
Multiple foci of bleeds were evident throughout the
striatum and cortex, and in some cases in the corpus
callosum and hippocampus (Figure 1A–1C). HT was
not detected in the contralateral hemisphere of ob/ob
mice, suggesting that HT was a consequence of the
ischaemic challenge and did not occur sponta-
neously in the absence of ischaemia in ob/ob mice.
The incidence of HT was significantly increased in
ob/ob mice as compared with that in the lean
controls (lean, n=1/6 versus ob/ob, n=5/6; P<0.05,
w2-test of independence). The HT observed in the one
lean mouse was restricted to a small striatal
haemorrhage. The volume of ischaemic brain damage
was significantly greater (120%) in ob/ob as
compared with that in lean mice 24h after MCAo
(P<0.05; Figure 1D and 1E). There were two
mortalities in the ob/ob group, and post mortem
examination of their brains revealed extensive brain
damage and HT.
Increased HT and Ischaemic Brain Damage in Obese
Mice are Independent of Leptin Deficiency
Neuroprotective actions of leptin have been demon-
strated previously (Zhang et al, 2007); therefore, in a
separate experiment, we assessed the effect of acute
leptin replacement on ischaemic brain damage in
lean and obese mice. Leptin administration did not
affect the incidence of HT, as haemorrhages were
present in the striatum and cortex of all ob/ob mice
(ob/ob vehicle, n=4/4 versus ob/ob leptin, n=4/4)
24 h after MCAo. The total area of HT in the
ischaemic tissue of ob/ob mice was also unaffected
by leptin treatment (ob/ob vehicle, 0.35±0.15mm2
versus ob/ob leptin, 0.56±0.09mm2; P>0.05). There
was no HTobserved in the brains of lean mice treated
with either vehicle or leptin (lean vehicle, n=0/6
versus lean leptin, n=0/5). Leptin administration
did not affect the exacerbation of ischaemic damage
observed in obese mice (Figure 1F). One mortality
after MCAo was noted in both obese groups (ob/ob
vehicle and ob/ob leptin) and a post-mortem exam-
ination of the brains of these mice revealed the
presence of HT and extensive ischaemic damage.
To verify that the absence of an effect of leptin
administration on brain pathology was not due to
lack of biological activity, we assessed the effect
of leptin on food intake and body weight. Leptin
(4mg/kg, intraperitoneal.) significantly reduced food
intake (vehicle, 4.0±0.2 g versus leptin, 3.2±0.3 g,
P<0.05; n=5–6) and caused body weight loss
(D body weight; vehicle, 0.2±0.1 g versus leptin,
0.4±0.1 g, P<0.01; n=5–6) 24h after injection in
lean mice.
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BBB Permeability and Brain Microvascular MMP-9
Expression are Increased after Focal Cerebral
Ischaemia in Obese Mice
The marked increase in susceptibility to ischaemia-
induced HT observed in ob/ob mice suggests
severe loss of BBB integrity and an increase in
cerebrovascular permeability. BBB permeability was
determined by assessing the accumulation of en-
dogenous IgG (which is excluded by an intact BBB)
in the brain by immunohistochemistry. There
was minimal IgG immunoreactivity in the brain
tissue of lean mice after MCAo (Figure 2A). Marked
increases in distribution and intensity of IgG
immunoreactivity were observed in the ipsilateral
hemisphere of brain sections from ob/ob mice 24h
after MCAo. Intense IgG staining was present in both
the striatum and cortex, corresponding to areas of
ischaemic damage.
Experimental and clinical evidence implicates
proteolytic disruption of BBB substrates by proteases
such as MMP-9 in cerebrovascular disruption.
We, therefore, assessed the expression of MMP-9 in
the brain of obese and lean mice after MCAo.
Extensive MMP-9 immunoreactivity was detected
in the ipsilateral ischaemic striatum and cortex of
ob/ob mice (Figure 2B), but not in the contralateral
hemisphere. No MMP-9-positive cells were seen in
the ipsilateral striatum or cortex of lean mice. The
majority of MMP-9 in ob/ob mice was localised to
blood vessels, which was confirmed by strong
colocalisation between MMP-9 and laminin, a major

























































Figure 1 HT and ischaemic damage are increased in obese mice 24h after MCAo. (A) Coronal brain sections stained
with haematoxylin and eosin illustrate discrete foci of haemorrhages (arrows) in the ipsilateral striatum and cortex of ob/ob mice.
(B) A higher magnification view of the area outlined by the dashed box in panel A. (C) The typical distribution of HT at six coronal
brain sections. (D) An increase in the volume of ischaemic brain damage was observed in obese ob/ob mice 24h after MCAo.
(E) Representative cresyl violet-stained brain sections illustrate the exacerbation of brain damage in ob/ob mice. (F) Increased
ischaemic damage in the brains of obese mice is independent of leptin. Leptin (4mg/kg, intraperitoneal) or vehicle was administered
at the onset of MCAo to lean and obese ob/ob mice and volume of ischaemic injury was assessed at 24 h. Data are mean±s.d. for
n=4–6 mice per group. *P<0.05, **P<0.01 and ***P<0.001 versus lean mice. Scale bars, 200 mm (A) and 25 mm (B).
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Figure 2 BBB permeability and MMP-9 expression are increased in obese mice after MCAo. BBB permeability was assessed by
immunostaining for IgG. (A) Representative sections from lean and obese ob/ob mice 24h after MCAo illustrate marked increased in
the intensity and distribution of IgG immunoreactivity in ob/ob mice in the cortex and striatum indicating greater BBB disruption in
obese mice. (B) Representative photomicrographs of MMP-9 expression in the brain of lean and obese ob/ob mice 24h after MCAo.
Increase in MMP-9 immunoreactivity was observed in the striatum and cortex of ob/ob mice. (C) Multi-labelling immunofluorescence
shows colocalisation of laminin-positive blood vessels (red) and MMP-9 expression (green) in ob/ob mice indicating that the majority
of MMP-9 is localised to cerebral blood vessels. Scale bars, 100 mm (B) and 25mm (C).
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Discussion
In the present study, we show elevated microvascu-
lar MMP-9 expression and increased incidence of HT
in obese, leptin-deficient ob/ob mice after experi-
mental stroke. BBB permeability and infarct volume
were also exacerbated in obese mice. Our data
suggest that these effects are not due to hyperglycae-
mia or leptin deficiency, and, therefore, implicate
obesity as an independent factor that promotes
severe brain microvascular disruption after ischae-
mic brain injury.
In addition to clinical data that have indicated
increased risk of stroke in obese individuals (Winter
et al, 2008), recent studies have shown that the
severity of brain damage is increased after experi-
mental stroke in obese rodents (Mayanagi et al, 2008;
Terao et al, 2008). Our data expand on these previous
findings to show that obese mice are highly suscep-
tible to HT, which is associated with elevated
microvascular MMP-9 immunoreactivity. HT is a
serious complication in ischaemic stroke patients
that correlates with poor prognosis (Paciaroni et al,
2008). Conventional risk factors for HT include
hyperglycaemia and hypertension (Paciaroni et al,
2008), both of which are common in obese subjects.
However, these factors are unlikely to account for the
increased frequency of HT in the present study,
because pre-ischaemic blood glucose levels were
similar in lean and obese mice, and previous studies
have not found significant differences in blood
pressure (Vachharajani et al, 2005). Thrombolytic
treatment also predisposes to HT (Zhao et al, 2007).
Our data suggest that obese patients may be at further
risk of HT if treated with thrombolytic agents.
The extravasation of all blood constituents, in-
cluding erythrocytes, that occurs during HT is
indicative of a catastrophic failure of microvascular
integrity. This failure also underlies the increased
permeability of the BBB and brain oedema that
accompanies HT. In the present study, we found
marked increase in BBB permeability to IgG in obese
mice, which is consistent with their increased
susceptibility to HT and confirms that obesity
promotes severe disruption to the BBB. We also
observed localisation of extensive MMP-9 immunor-
eactivity to the microvasculature in obese mice,
suggesting that MMP-9 may be an important med-
iator underlying increased BBB disruption and HT in
obese mice. Quantitative assays of MMP-9 activity
will be required to verify changes on a functional
level. Previous studies have shown that MMP-9 can
disrupt multiple components of the BBB, including
the tight-junction proteins claudin-5 and occludin,
and the basement membrane protein collagen-IV
(Candelario-Jalil et al, 2009). Furthermore, inhibition
of MMPs attenuates BBB disruption and reduces
thrombolysis-induced HT after experimental stroke
(Candelario-Jalil et al, 2009).
A chronically elevated inflammatory profile is a
feature of obesity and inflammation is implicated in
microvascular dysfunction associated with obesity
(Singer and Granger, 2007). Increased leukocyte–
endothelium interactions and intracellular adhesion
molecule-1 (ICAM-1) expression after experimental
stroke in obese mice have recently been reported
(Mayanagi et al, 2008; Terao et al, 2008). Leukocytes,
in particular neutrophils, contain abundant pro-
teases, including MMP-9; therefore, increased leuko-
cyte adhesion could be a mechanism underlying the
increased microvascular MMP-9 expression in the
present study. In support of this, brain neutrophil
accumulation was significantly greater after MCAo in
obese mice (data not shown). More generally, grow-
ing evidence suggests that systemic inflammatory
conditions, such as obesity, are important modifiers
of stroke outcome (McColl et al, 2009).
One important caveat of the present study is that
we cannot exclude that the effects of obesity are
mediated through alterations in cerebral perfusion
(e.g., through collateral vessels) and, indeed, given
the pro-coagulatory state that is associated with
obesity, it will be important to consider this potential
mechanism in future studies. In summary, we have
shown that obese ob/ob mice are highly susceptible
to HT after experimental stroke, an effect that is
associated with increased microvascular MMP-9
expression and BBB opening. Further work is
ongoing to explore the mechanisms in more detail.
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